Literature DB >> 9718635

Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort.

P Räsänen1, J Tiihonen, M Isohanni, P Rantakallio, J Lehtonen, J Moring.   

Abstract

It has been suggested that schizophrenia and alcoholism are associated with violent behavior. But so far there are no published studies from unselected cohorts quantifying the actual risk associated with schizophrenia both with and without comorbid alcoholism. In this study, an unselected birth cohort (n = 11,017) was prospectively followed to the age of 26, and data on psychiatric disorders and crimes were collected from national registers. The odds ratios for violent offenses and recidivism were calculated for each diagnostic group. Men who abused alcohol and were diagnosed with schizophrenia were 25.2 (95% confidence interval (CI) 6.1-97.5) times more likely to commit violent crimes than mentally healthy men. The risk for nonalcoholic patients with schizophrenia was 3.6 (95% CI 0.9-12.3) and for other psychoses, 7.7 (95% CI 2.2-23.9). None of the patients with schizophrenia who did not abuse alcohol were recidivists (> 2 offenses), but the risk for committing more crimes among alcoholic subjects with schizophrenia was 9.5-fold (95% CI 2.7-30.0). This study suggests that to prevent the crimes being committed by people with schizophrenia, it is important that clinicians watch for comorbid alcohol abuse.

Entities:  

Mesh:

Year:  1998        PMID: 9718635     DOI: 10.1093/oxfordjournals.schbul.a033338

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  28 in total

1.  Early risk factors for criminal offending in schizophrenia: a 35-year longitudinal cohort study.

Authors:  Asa Eriksson; Anders Romelsjö; Marlene Stenbacka; Anders Tengström
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-07-04       Impact factor: 4.328

Review 2.  [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].

Authors:  T Wobrock; R D'Amelio; P Falkai
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 3.  Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment.

Authors:  Jennifer P Wisdom; Jennifer I Manuel; Robert E Drake
Journal:  Psychiatr Serv       Date:  2011-09       Impact factor: 3.084

4.  Treatment patterns among offenders with mental health problems and substance use problems.

Authors:  Charlotte Alm; Åsa Eriksson; Tom Palmstierna; Marianne Kristiansson; Anne H Berman; Clara Hellner Gumpert
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

5.  [Substance use associated disorders: frequency in patients with schizophrenic and affective psychoses].

Authors:  L Hermle; R Szlak-Rubin; K L Täschner; P Peukert; A Batra
Journal:  Nervenarzt       Date:  2013-03       Impact factor: 1.214

6.  The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.

Authors:  Michael T Compton; Paul S Weiss; Joyce C West; Nadine J Kaslow
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-25       Impact factor: 4.328

7.  Characteristics of immigrant and non-immigrant patients in a dual-diagnosis psychiatric ward and treatment implications.

Authors:  Sophie D Walsh; David Blass; Meital Bensimon-Braverman; Lee Topaz Barak; Yael Delayahu
Journal:  J Immigr Minor Health       Date:  2014-12

Review 8.  Schizophrenia and violence: systematic review and meta-analysis.

Authors:  Seena Fazel; Gautam Gulati; Louise Linsell; John R Geddes; Martin Grann
Journal:  PLoS Med       Date:  2009-08-11       Impact factor: 11.069

9.  A comparison of schizophrenic patients with or without coexisting substance use disorder.

Authors:  Coreen Farris; Christiane Brems; Mark E Johnson; Rebecca Wells; Randall Burns; Nicholas Kletti
Journal:  Psychiatr Q       Date:  2003

10.  Schizophrenia, substance abuse, and violent crime.

Authors:  Seena Fazel; Niklas Långström; Anders Hjern; Martin Grann; Paul Lichtenstein
Journal:  JAMA       Date:  2009-05-20       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.